Analytical Data
-
Gene name
BMP9
- Application
-
Alternative Names
BMP9；BMP9；Growth/differentiation factor 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UK05
-
Expression Region
320-429aa
-
AA Sequence
SAGAGSHCQK TSLRVNFEDI GWDSWIIAPK EYEAYECKGG CFFPLADDVT PTKHAIVQTL VHLKFPTKVG KACCVPTKLS PISVLYKDDM GVPTLKYHYE GMSVAECGCR
-
Molecular Weight
24 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Bone morphogenetic protein 9 (BMP9), a member of the BMP family, has garnered significant attention in recent years due to its crucial role in various biological processes, including bone formation, hematopoiesis, and vascular development. Initially isolated from a human osteoblast cell line, BMP9 is known for its potent osteoinductive properties, making it a potential candidate for therapeutic applications in bone regeneration and repair. Recent studies have highlighted BMP9's role in regulating angiogenesis and its involvement in pathological conditions such as fibrosis and cancer. The recombinant production of BMP9 has become increasingly feasible through advancements in biotechnological methods, allowing for the generation of large quantities of this protein for research and potential clinical use. Understanding the signaling pathways and molecular mechanisms through which BMP9 exerts its effects is essential for harnessing its therapeutic potential. Moreover, the study of BMP9's interactions with other signaling molecules can provide insights into its diverse physiological roles and its potential implications in tissue engineering and regenerative medicine. As research continues to unravel the complexity of BMP9 functions, it remains a promising candidate for innovative treatments in various musculoskeletal and cardiovascular disorders.
